Does Bright Minds Biosciences Inc. (DRUG) Have the Potential to Rally 114.07% as Wall Street Analysts Expect?

Bright Minds Biosciences Inc. (DRUG) closed the last trading session at $38.89, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 83.25 indicates an 114.1% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $7.68. While the lowest estimate of$ 75.00 indicates a 92.9% increase from the current price level, the most opt ...